Variant report
Variant | esv3452525 |
---|---|
Chromosome Location | chr1:158489480-158492137 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:3 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr1:158491160-158491310 | GM12867 | blood: | n/a | n/a |
2 | E2F4 | chr1:158491949-158492004 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | STAT3 | chr1:158490840-158490870 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000231434 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7339982 | chr1:158489481-158489482 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs549898150 | chr1:158489490-158489491 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs568102934 | chr1:158489511-158489512 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs369801163 | chr1:158489538-158489539 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs35024434 | chr1:158489551-158489552 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs181364032 | chr1:158489587-158489588 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs180967288 | chr1:158490815-158490816 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs547153467 | chr1:158490846-158490847 | Bivalent Enhancer Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs113669593 | chr1:158490865-158490866 | Bivalent Enhancer Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs549962066 | chr1:158490876-158490877 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs186168475 | chr1:158490883-158490884 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs532801562 | chr1:158490892-158490893 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs143280358 | chr1:158490909-158490910 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs569639535 | chr1:158490919-158490920 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs113273299 | chr1:158490940-158490941 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183012306 | chr1:158491098-158491099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs61560285 | chr1:158491203-158491204 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs77205466 | chr1:158491216-158491217 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs543369850 | chr1:158491246-158491247 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs553964237 | chr1:158491250-158491251 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs572461556 | chr1:158491376-158491377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs187675948 | chr1:158491415-158491416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs558155975 | chr1:158491427-158491428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs576820546 | chr1:158491428-158491429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs544110506 | chr1:158491429-158491430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs1491193 | chr1:158491479-158491480 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs574146933 | chr1:158491480-158491481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs541574771 | chr1:158491496-158491497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs950260 | chr1:158491520-158491521 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs12067180 | chr1:158491538-158491539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs533020915 | chr1:158491562-158491563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs550980271 | chr1:158491593-158491594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs562929305 | chr1:158491601-158491602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs542589433 | chr1:158491633-158491634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs527286086 | chr1:158491641-158491642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs530741658 | chr1:158491651-158491652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs190952853 | chr1:158491653-158491654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs567495206 | chr1:158491654-158491655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528282912 | chr1:158491669-158491670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs546726992 | chr1:158491687-158491688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs59758212 | chr1:158491693-158491694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs1491194 | chr1:158491699-158491700 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs536161821 | chr1:158491708-158491709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs7416481 | chr1:158491719-158491720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs369444423 | chr1:158491722-158491723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs2317969 | chr1:158491753-158491754 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs570041836 | chr1:158491791-158491792 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs551605516 | chr1:158491793-158491794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs7518808 | chr1:158491820-158491821 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs574229277 | chr1:158491870-158491871 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 17899364 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Type 2 diabetes | 19141583 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21509527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Systemic lupus erythematosus | 19220326 | CNVD |
Systemic lupus erythematosus | 19287148 | CNVD |
Glomerulonephritis | 19341492 | CNVD |
Systemic lupus erythematosus | 18559452 | CNVD |
Systemic autoimmune disease | 17597778 | CNVD |
Glomerulonephritis | 17008540 | CNVD |
Glomerulonephritis | 16482158 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Cancer | 17060936 | CNVD |
Lung cancer | 16740712 | CNVD |
Breast cancer | 21804112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Breast cancer | 21045282 | CNVD |
Cancer | 20164920 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:158489400-158489600 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr1:158490800-158491000 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr1:158490800-158492000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr1:158491000-158491200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr1:158491000-158491600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
6 | chr1:158491000-158491600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr1:158491000-158491800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr1:158491600-158491800 | Enhancers | H1 Cell Line | embryonic stem cell |
9 | chr1:158491600-158492000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
10 | chr1:158491800-158496800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
11 | chr1:158491800-158497400 | Weak transcription | H1 Cell Line | embryonic stem cell |
12 | chr1:158492000-158497200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |